Manns Home Medical Products is categorized under Chair Beds in Mc Keesport, PA and active since 1966.
Manns Home Medical Products was established in 1966, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Chair Beds business, which does work in the BOTH market, and is classified as a Chair Beds, under code number 4234501 by the NAICS.
If you are seeking more information, feel free to contact Walter Manns, Owner at the company’s single location by writing to 1101 Lincoln Way, Mc Keesport, Pennsylvania PA 15131 or by phoning (412) 672-5680. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Manns Home Medical Products |
| Contact Person: | Walter Manns, Owner |
| Address: | 1101 Lincoln Way, Mc Keesport, Pennsylvania 15131 |
| Phone Number: | (412) 672-5680 |
| Website Address: | mymanns.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 1966 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Chair Beds |
| SIC Code: | 2515 |
| NAICS Code: | 4234501 |
| Share This Business: |
Manns Home Medical Products was started in 1966 to provide professional Chair Beds under the SIC code 2515 and NAICS code 4234501. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Walter Manns, Owner for inquiries that concern Manns Home Medical Products by calling the company number (412) 672-5680, as your correspondence is most welcome. Additionally, the physical location of the single location of Manns Home Medical Products can be found at the coordinates 40.35376,-79.82364 as well as the street address 1101 Lincoln Way in Mc Keesport, Pennsylvania 15131.
For its online presence, you may visit Manns Home Medical Products’s website at mymanns.com and engage with its social media outlets through on Twitter and on Facebook.